116 related articles for article (PubMed ID: 25275204)
1. Effects of vanadium complexes supplementation on V, Cu, Mn, K, Fe, Zn, and Ca concentration in STZ diabetic rats pancreas.
Krośniak M; Kowalska J; Francik R; Gryboś R; Kwiatek WM
Acta Pol Pharm; 2014; 71(4):583-92. PubMed ID: 25275204
[TBL] [Abstract][Full Text] [Related]
2. Effects of vanadium complexes supplementation on V, Fe, Cu, Zn, Mn, Ca and K concentration in STZ diabetic rat's spleen.
Krośniak M; Francik R; Kowalska J; Gryboś R; Blusz M; Kwiatek WM
Acta Pol Pharm; 2013; 70(1):71-7. PubMed ID: 23610961
[TBL] [Abstract][Full Text] [Related]
3. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
5. Influence of vanadium-organic ligands treatment on selected metal levels in kidneys of STZ rats.
Krośniak M; Kowalska J; Francik R; Gryboś R; Blusz M; Kwiatek WM
Biol Trace Elem Res; 2013 Jun; 153(1-3):319-28. PubMed ID: 23661329
[TBL] [Abstract][Full Text] [Related]
6. Control and STZ-diabetic rat liver Golgi complexes under the influence of bis(2,2'-bipyridine)oxovanadium(IV) sulphate. The morphological investigation.
Dabroś W; Kajda B; Kordowiak AM
Pol J Pathol; 2002; 53(3):123-8. PubMed ID: 12476613
[TBL] [Abstract][Full Text] [Related]
7. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
[TBL] [Abstract][Full Text] [Related]
8. Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats.
Kurt O; Ozden TY; Ozsoy N; Tunali S; Can A; Akev N; Yanardag R
Biometals; 2011 Oct; 24(5):943-9. PubMed ID: 21479831
[TBL] [Abstract][Full Text] [Related]
9. Hydrothermal syntheses and structural characterizations of organic-inorganic hybrid materials of the M(II)-ligand/vanadium oxide system (M(II) = Mn(II), Cu(II) and Zn(II); ligand = 2,2'-bipyridine and 1,10-phenanthroline).
Yi ZH; Cui XB; Zhang X; Yu JH; Lu J; Xu JQ; Yang GD; Wang TG; Yu HH; Duan WJ
Dalton Trans; 2007 Jun; (21):2115-20. PubMed ID: 17514331
[TBL] [Abstract][Full Text] [Related]
10. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
11. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part II. Prolonged treatmentwith vanadium compound.
Dabroś W; Gryboś R; Miarka A; Kordowiak AM
Pol J Pathol; 2000; 51(1):17-24. PubMed ID: 10833899
[TBL] [Abstract][Full Text] [Related]
13. The effects of vanadium (V) absorbed by Coprinus comatus on bone in streptozotocin-induced diabetic rats.
Pei Y; Fu Q
Biol Trace Elem Res; 2011 Sep; 142(3):748-59. PubMed ID: 20734239
[TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant activity of melatonin in diabetes in relation to the regulation and levels of plasma Cu, Zn, Fe, Mn, and Se in Zucker diabetic fatty rats.
Navarro-Alarcon M; Ruiz-Ojeda FJ; Blanca-Herrera RM; Agil A
Nutrition; 2013 May; 29(5):785-9. PubMed ID: 23352467
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin-diabetic rats.
Krosniak M; Zachwieja Z; Filipek B; Zygmunt M; Grybos R
Arch Pharm (Weinheim); 2001 Dec; 334(12):388-92. PubMed ID: 11852534
[TBL] [Abstract][Full Text] [Related]
17. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Dziga D; Kordowiak AM
Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
[TBL] [Abstract][Full Text] [Related]
18. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
19. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats.
Gao LH; Liu WP; Wang BL; Li L; Xie MJ; Li YR; Chen ZH; Chen XZ
Clin Chim Acta; 2006 Jun; 368(1-2):173-8. PubMed ID: 16487949
[TBL] [Abstract][Full Text] [Related]
20. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R; Giridhar R; Yadav MR
J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
